Abstract
Background
A fixed-dose combination tablet of tramadol/acetaminophen exhibits both rapid and
sustained analgesic effects due to different pharmacologic activities. To prolong
analgesia and improve patient convenience, an extended-release (ER) tablet of this
agent has been developed.
Objective
The aim of this study was to explore the pharmacokinetic profiles of the new ER tramadol/acetaminophen
fixed-dose combination and compare them with those of a conventional immediate-release
(IR) formulation after multiple dosing as a Phase I clinical exploratory trial.
Methods
An open-label, randomized, 2-sequence crossover study was conducted in healthy volunteers.
All subjects received both formulations for 4 days: either 1 IR tablet (tramadol 37.5
mg/acetaminophen 325 mg) q6h followed by 1 ER tablet (tramadol 75 mg/acetaminophen
650 mg) q12h, or vice versa. A 5-day washout period separated the 2 treatments. Tramadol
and acetaminophen concentrations in plasma were determined simultaneously using LC-MS/MS,
and the pharmacokinetic properties were analyzed by noncompartmental method. To compare
the systemic exposure of the 2 formulations, the geometric mean ratios (GMRs) for
AUC0–12,ss and the 90% CIs were calculated. Adverse events (AEs) were identified through subject
interviews, recording of vital signs, physical examinations, 12-lead electrocardiography,
and clinical laboratory assessments.
Results
Twelve healthy, nonsmoking, Korean male subjects completed the study. The mean (SD)
age was 24.4 (5.2) years and the mean body weight was 65.1 (6.0) kg. The Tmax,ss for tramadol was delayed until 3 hours after the ER treatment, compared with 1 hour
after the IR treatment, whereas the Tmax,ss of acetaminophen was 30 minutes after each treatment. The mean (SD) of AUC0–12,ss in the IR and ER formulations was 2789.0 (507.7) and 2638.7 (469.1) µg/h/L for tramadol
and 42,635.0 (8711.2) and 40,394.3 (10,127.7) µg/h/L for acetaminophen, respectively.
The GMR of ER to IR for AUC0–12,ss was 0.95 (90% CI, 0.91–0.99) for tramadol and 0.94 (90% CI, 0.89–0.99) for acetaminophen.
A total of 17 AEs occurred in 9 subjects; all AEs were considered mild or moderate
and resolved without medical intervention. The most frequent AEs were headache and
dizziness (3 cases each).
Conclusions
The ER formulation displayed a similar AUC0–12,ss to that of the IR formulation for tramadol and acetaminophen.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Tramadol: basic pharmacology and emerging concepts.Drugs Today (Barc). 2008; 44: 827-836
- Tramadol: a review of its use in perioperative pain.Drugs. 2000; 60: 139-176
- Clinical pharmacology of tramadol.Clin Pharmacokinet. 2004; 43: 879-923
- Analgesic efficacy and safety of tramadol enantiomers in comparison with the racemate: a randomised, double-blind study with gynaecological patients using intravenous patient-controlled analgesia.Pain. 1995; 62: 313-320
- Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia.Pain. 2008; 139: 190-200
- What do we (not) know about how paracetamol (acetaminophen) works?.J Clin Pharm Ther. 2010; 35: 617-638
- Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram.Life Sci. 1996; 58 (PL 23–28)
- Supra-additive effects of tramadol and acetaminophen in a human pain model.Pain. 2008; 136: 262-270
- Tramadol and acetaminophen tablets for dental pain.Anesth Prog. 2001; 48: 79-81
- Combination analgesic efficacy: individual patient data meta-analysis of single-dose oral tramadol plus acetaminophen in acute postoperative pain.J Pain Symptom Manage. 2002; 23: 121-130
- A double-blind placebo-controlled comparison of tramadol/acetaminophen and tramadol in patients with postoperative dental pain.Pain. 2004; 109: 250-257
- Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain.Eur J Anaesthesiol Suppl. 2003; 28: 19-22
- Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.J Rheumatol. 2004; 31: 150-156
- Analgesic efficacy and safeAnalgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.J Rheumatol. 2004; 31: 2454-2463
- Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis.J Am Geriatr Soc. 2005; 53 (author reply 165–166): 165
- Tramadol/acetaminophen tablets in the treatment of postsurgical orthopedic pain.Am J Orthop (Belle Mead NJ). 2005; 34: 592-597
- Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.Curr Med Res Opin. 2007; 23: 147-161
- Ultracet® (tramadol hydrochloride/acetaminophen) Tablets.([prescribing information]) Ortho-McNeil Pharmaceutical, Raritan, NJ2009
- Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain.J Rheumatol. 2001; 28: 182-184
- Simultaneous determination of tramadol and acetaminophen in human plasma by LC-ESI-MS.Chromatographia. 2007; 66: 171-178
- Bioavailability of enteral tramadol formulations.Arzneimittelforschung. 1986; 36: 1278-1283
- Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain.J Opioid Manag. 2008; 4: 285-292
- A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol).Acad Emerg Med. 1996; 3: 740-744
- Combination analgesia in 2005—a rational approach: focus on paracetamol-tramadol.Clin Rheumatol. 2006; 25: S16-S21
- Clinical pharmacology and rationale of analgesic combinations.Eur J Anaesthesiol Suppl. 2003; 28: 7-11
- Pharmacokinetics and saliva secretion of paracetamol in healthy male Nigerians.West Afr J Med. 2004; 23: 10-14
- Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects.J Clin Pharm Ther. 2005; 30: 179-184
- Tramadol/paracetamol.Drugs. 2003; 63 (discussion 1087–1078): 1079-1086
- Pharmacokinetic interaction between acetaminophen and lansoprazole.J Clin Gastroenterol. 1999; 29: 56-58
- The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol.BMC Clin Pharmacol. 2010; 10: 10
- Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status.Aliment Pharmacol Ther. 2004; 20: 29-36
- Tramadol/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain.Clin Drug Investig. 2010; 30 ([published correction appears in Clin Drug Investig. 2010;30:866]): 711-738
- Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers.Biopharm Drug Dispos. 2007; 28: 527-534
- The metabolism of tramadol by human liver microsomes.Clin Investig. 1992; 70: 708-710
- Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites.Curr Med Res Opin. 2007; 23: 1593-1604
- Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.Biopharm Drug Dispos. 2007; 28: 19-33
Article info
Publication history
Accepted:
April 27,
2011
Identification
Copyright
© 2011 Elsevier HS Journals, Inc. Published by Elsevier Inc. All rights reserved.